CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 216 enrolled
Drug / intervention
Hesperidin +1 moredrug
Likely dose
Hesperidin 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04715932
NCT04715932Phase 2Completed
CompareCT.gov

A Phase 2, Randomized, Double-blind, Placebo-controlled Study of Hesperidin Therapy on COVID-19 Symptoms: The Hesperidin Coronavirus Study (Hesperidin)

Montreal Heart Institute·interventional·Posted Jan 20, 2021·Updated Apr 8, 2022

In Brief

A Phase 2 clinical trial evaluating Hesperidin and Placebo for Covid19 and 16 related conditions. Completed, enrolled 216 participants across 1 site.

Detailed Summary

The main aim of this study is to determine the effects of short-term treatment with hesperidin on COVID-19 symptoms in comparison with a placebo. Treatment effects will be observed through a symptoms diary that will be completed by participants throughout the study and by taking the oral temperature daily.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19, Anosmia, Fever, Cough, Shortness of Breath, Sore Throat, Nausea, Vomiting, Headache, Muscle Weakness, Pain, Muscle, Pain, Chest, Pain, Joint, Pain, Abdominal, Pain, Irritable Mood, Confusion
CountriesCanada
CollaboratorsIngenew Pharmaceuticals Inc.

Timeline

Phase 2CompletedFinished
202120222023202420252026
First PostedJan 20, 2021
Enrollment StartFeb 18, 2021
Primary CompletionMay 25, 2021
Study CompletionJun 7, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.5 years ago

Interventions

Hesperidindrug

Patients will receive study medication Hesperidin and will take 2 capsules of 500mg at the same time in the evening, at bedtime with water.

Placebodrug

Patients will receive study medication Placebo and will take 2 capsules of 500mg at the same time in the evening, at bedtime with water.